The variable plasma quercetin response to 12-week quercetin supplementation in humans
- PMID: 20517329
- DOI: 10.1038/ejcn.2010.91
The variable plasma quercetin response to 12-week quercetin supplementation in humans
Abstract
Background/objectives: Quercetin supplementation results in a variable plasma quercetin response in humans. The purpose of this study was to determine whether this variance is related to gender, age, body mass index (BMI), and other demographic and lifestyle factors.
Subjects/methods: Subjects (N=1002, ages 18-85 years, 60% female and 40% male) were recruited from the community and randomized to one of three groups, with supplements administered using double-blinded procedures: Q-500 (500 mg/day), Q-1000 (1000 mg/day), or placebo. Subjects ingested two soft chew supplements twice daily during the 12-week study. Fasting blood samples were obtained pre- and post-study, analyzed for plasma quercetin, and then compared between and within groups by gender, age group (<40, 40-59, and >or=60 years), BMI (<25, 25-29.9, and >or=30 kg/m(2)), self-reported physical fitness level, and diet intake (food group servings).
Results: Quercetin supplementation over 12 weeks caused a significant increase in overnight-fasted plasma quercetin, with a net increase of 332+/-21.0 and 516+/-30.8 microg/l for Q-500 and Q-1000 compared with 53.6+/-6.4 microg/l for placebo (interaction effect, P<0.001). The increase in plasma quercetin was highly variable within each quercetin supplementation group, but was unrelated to age, gender, BMI, fitness levels, or diet intake.
Conclusions: In summary, quercetin supplementation in doses of 500 and 1000 mg/day caused large but highly variable increases in plasma quercetin that were unrelated to demographic or lifestyle factors.
Similar articles
-
Quercetin supplementation does not alter antioxidant status in humans.Free Radic Res. 2010 Feb;44(2):224-31. doi: 10.3109/10715760903407293. Free Radic Res. 2010. PMID: 19947898
-
A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects.Br J Nutr. 2010 Sep;104(6):849-57. doi: 10.1017/S000711451000156X. Epub 2010 May 26. Br J Nutr. 2010. PMID: 20500927 Clinical Trial.
-
Influence of quercetin supplementation on disease risk factors in community-dwelling adults.J Am Diet Assoc. 2011 Apr;111(4):542-9. doi: 10.1016/j.jada.2011.01.013. J Am Diet Assoc. 2011. PMID: 21443986 Clinical Trial.
-
Quercetin supplementation and its effect on human monocyte gene expression profiles in vivo.Br J Nutr. 2010 Aug;104(3):336-45. doi: 10.1017/S0007114510000711. Epub 2010 Apr 26. Br J Nutr. 2010. PMID: 20416132 Clinical Trial.
-
Dose-response to 3 months of quercetin-containing supplements on metabolite and quercetin conjugate profile in adults.Br J Nutr. 2013 Jun;109(11):1923-33. doi: 10.1017/S0007114512003972. Epub 2012 Nov 14. Br J Nutr. 2013. PMID: 23151341 Clinical Trial.
Cited by
-
The Impact of Three-Month Quercetin Intake on Quality of Life and Anxiety in Patients With Type II Diabetes Mellitus: An Early Data Analysis From a Randomized Controlled Trial.Cureus. 2024 Apr 14;16(4):e58219. doi: 10.7759/cureus.58219. eCollection 2024 Apr. Cureus. 2024. PMID: 38745810 Free PMC article.
-
A Pharmacokinetic Study of Different Quercetin Formulations in Healthy Participants: A Diet-Controlled, Crossover, Single- and Multiple-Dose Pilot Study.Evid Based Complement Alternat Med. 2023 Aug 10;2023:9727539. doi: 10.1155/2023/9727539. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 37600550 Free PMC article.
-
Potential Role of Quercetin Glycosides as Anti-Atherosclerotic Food-Derived Factors for Human Health.Antioxidants (Basel). 2023 Jan 23;12(2):258. doi: 10.3390/antiox12020258. Antioxidants (Basel). 2023. PMID: 36829817 Free PMC article. Review.
-
Potential of Vasoprotectives to Inhibit Non-Enzymatic Protein Glycation, and Reactive Carbonyl and Oxygen Species Uptake.Int J Mol Sci. 2021 Sep 16;22(18):10026. doi: 10.3390/ijms221810026. Int J Mol Sci. 2021. PMID: 34576189 Free PMC article.
-
Exhaustion of Protective Heat Shock Response Induces Significant Tumor Damage by Apoptosis after Modulated Electro-Hyperthermia Treatment of Triple Negative Breast Cancer Isografts in Mice.Cancers (Basel). 2020 Sep 10;12(9):2581. doi: 10.3390/cancers12092581. Cancers (Basel). 2020. PMID: 32927720 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical